| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 05/26/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 04/28/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 04/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/28/2023 |
8-K
| Quarterly results |
| 02/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.1% stake in HealthStream Inc. |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 13.8% stake in HEALTHSTREAM INC |
| 01/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/03/2023 |
8-K
| Quarterly results |
| 10/27/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/24/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/25/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
8-K
| Quarterly results |
| 05/26/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/18/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/25/2022 |
8-K
| Quarterly results |
| 04/14/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/29/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/14/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/28/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/22/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.7% stake in HealthStream Inc. |
|